JP2024536360A5 - - Google Patents
Info
- Publication number
- JP2024536360A5 JP2024536360A5 JP2024520688A JP2024520688A JP2024536360A5 JP 2024536360 A5 JP2024536360 A5 JP 2024536360A5 JP 2024520688 A JP2024520688 A JP 2024520688A JP 2024520688 A JP2024520688 A JP 2024520688A JP 2024536360 A5 JP2024536360 A5 JP 2024536360A5
- Authority
- JP
- Japan
- Prior art keywords
- rna
- binding protein
- peptide
- optionally
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021903192A AU2021903192A0 (en) | 2021-10-06 | Lipid nanoparticle comprising a RNA-binding protein | |
| AU2021903192 | 2021-10-06 | ||
| PCT/IB2022/059527 WO2023057935A1 (en) | 2021-10-06 | 2022-10-06 | Lipid nanoparticle comprising a nucleic acid-binding protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536360A JP2024536360A (ja) | 2024-10-04 |
| JP2024536360A5 true JP2024536360A5 (enExample) | 2025-10-01 |
Family
ID=85803963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520688A Pending JP2024536360A (ja) | 2021-10-06 | 2022-10-06 | 核酸結合タンパク質を含む脂質ナノ粒子 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240398941A1 (enExample) |
| EP (1) | EP4412592A4 (enExample) |
| JP (1) | JP2024536360A (enExample) |
| AU (1) | AU2022361756B2 (enExample) |
| WO (1) | WO2023057935A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024209404A1 (en) * | 2023-04-05 | 2024-10-10 | Seqirus Inc. | Rna delivery vehicle |
| CN120617495A (zh) * | 2025-07-16 | 2025-09-12 | 深圳纳维疫苗科技有限公司 | 一种hpv重组蛋白治疗疫苗的制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6210707B1 (en) * | 1996-11-12 | 2001-04-03 | The Regents Of The University Of California | Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| JP2006506101A (ja) * | 2002-11-13 | 2006-02-23 | ルトガーズ、ザ ステイト ユニバーシティ | インフルエンザウイルス非構造タンパク質１の阻害剤を設計する方法 |
| WO2010087994A2 (en) * | 2009-01-30 | 2010-08-05 | Whitehead Institute For Biomedical Research | Methods for ligation and uses thereof |
| BR112014024131A2 (pt) * | 2012-03-29 | 2017-07-25 | Shire Human Genetic Therapies | lipídios catiônicos ionizáveis |
| CA2879261C (en) * | 2012-07-19 | 2022-12-06 | Oxford Nanopore Technologies Limited | Modified helicases |
| WO2015061409A1 (en) * | 2013-10-23 | 2015-04-30 | University Of Washington Through Its Center For Commercialization | Universal protein tag for double stranded nucleic acid delivery |
| PL4023249T3 (pl) * | 2014-04-23 | 2025-03-10 | Modernatx, Inc. | Szczepionki z kwasem nukleinowym |
-
2022
- 2022-10-06 JP JP2024520688A patent/JP2024536360A/ja active Pending
- 2022-10-06 US US18/699,125 patent/US20240398941A1/en active Pending
- 2022-10-06 EP EP22878053.2A patent/EP4412592A4/en active Pending
- 2022-10-06 WO PCT/IB2022/059527 patent/WO2023057935A1/en not_active Ceased
- 2022-10-06 AU AU2022361756A patent/AU2022361756B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024536360A5 (enExample) | ||
| Liang et al. | Endosomal escape pathways for non-viral nucleic acid delivery systems | |
| JP2023512833A (ja) | 新型コロナウイルス感染症に対するｍＲＮＡワクチンの組成物及び方法 | |
| Lindberg et al. | PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors | |
| JP2011525190A5 (enExample) | ||
| CN102892420A (zh) | 用于递送寡核苷酸的新型单一化学实体和方法 | |
| JP2014515762A5 (enExample) | ||
| WO2007056861A1 (en) | Sirna silencing of influenza virus gene expression | |
| HRP20191400T1 (hr) | Peptidi i nanočestice za unutarstaničnu isporuku molekula | |
| Yang et al. | Multivalent oleanolic acid human serum albumin conjugate as nonglycosylated neomucin for influenza virus capture and entry inhibition | |
| JP2012522802A5 (enExample) | ||
| FR2763943A1 (fr) | Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules | |
| WO2010042749A2 (en) | Chimeric therapeutics, compositions, and methods for using same | |
| CN116018405A (zh) | Trem组合物及其相关方法 | |
| AU2018313940A1 (en) | Peptides and nanoparticles for intracellular delivery of virus | |
| CN105377305A (zh) | 靶向脂肪细胞的非病毒基因递送体系 | |
| Eldredge et al. | Dendritic peptide bolaamphiphiles for siRNA delivery to primary adipocytes | |
| CA3194161A1 (en) | Nucleoside containing sirnas for treating viral diseases | |
| JP2023504186A (ja) | 標的化された核酸送達のためのペプチドドッキング賦形剤 | |
| CN114832100A (zh) | 一种以RBD靶向递送shRNA的nCOVsiRNA药物制备方法 | |
| WO2022202816A1 (ja) | ペプチド及びペプチドを含む組成物 | |
| Wancewicz et al. | Peptide nucleic acids conjugated to short basic peptides show improved pharmacokinetics and antisense activity in adipose tissue | |
| AU2022361756B2 (en) | Lipid nanoparticle comprising a nucleic acid-binding protein | |
| Reynolds et al. | Polymers in the Delivery of siRNA for the Treatment of Virus Infections | |
| Fröhlich et al. | Peptide-and polymer-based delivery of therapeutic RNA |